TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Brii Biosciences Limited ( (HK:2137) ).
Brii Biosciences Limited announced the grant of 600,000 share options to a service provider under its 2023 Share Option Scheme. This move is part of the company’s strategic initiatives to enhance its operational capabilities and retain key advisory services, potentially impacting its market positioning by aligning interests with stakeholders.
The most recent analyst rating on (HK:2137) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Brii Biosciences Limited stock, see the HK:2137 Stock Forecast page.
More about Brii Biosciences Limited
Brii Biosciences Limited is a biotechnology company focused on developing innovative therapies for infectious diseases. The company operates in the biopharmaceutical industry, providing scientific and strategic advisory services.
Average Trading Volume: 7,002,246
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.36B
Learn more about 2137 stock on TipRanks’ Stock Analysis page.